I first wrote a blog post of this story yesterday.
by David Prentice
December 14, 2009
The latest success story comes from Australia. Ben Leahy, 20, was in a wheelchair and experiencing vision problems when he was treated earlier in 2009. Ben is now walking after treatment with adult stem cells. The treatment involves isolating the patient’s bone marrow adult stem cells, giving the patient mild chemotherapy to destroy the rogue immune cells that are attacking the nervous system, then re-injecting the patient’s adult stem cells.
While the Australian group has not yet published their results, the technique mirrors the treatment results published in 2009 in Lancet Neurology by Dr. Richard Burt’s team at Northwestern, where they reported that they had reversed the neurological dysfunction of early-stage multiple sclerosis patients.
As Dr. Burt noted:
“This is the first time we have turned the tide on this disease.”
CLICK HERE to continue reading and to watch MS Patient videos of this treatment
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Keep up-to-date with MS related News (as seen above), when registered with us. Visit our website to register NOW. It will not take more than 30 seconds to register and once accomplished, you will then receive our weekly MS related e-Newsletter, which is currently being received in 58 countries by more than 6000 e-recipients. Click HERE to register. – Thank You
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
Categories
Latest Blog Posts
- Four distinct paths of disability progression emerge in relapsing MS
- Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
- video: Reduce MS Symptoms: Exercises to Improve Walking
- Just 15 Minutes of Exercise Can Help Counteract the Health Risks of Sitting All Day
- How to Fit in More Steps Every Day
- Treatment effects of monthly intravenous immunoglobulin on patients with relapsing – remitting Multiple Sclerosis: Further analyses of the Austrian immunoglobulin in MS Study
- Mediterranean diet and risk of multiple sclerosis: A prospective cohort study
- What people with MS and care partners need to know about advancements in monitoring MS activity
- CONNECT with Our MS Community Chat
- Curious about MS infusion centers vs hospitals?
- Muscle Atrophy: 5 Exercises to Build Strength
- Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
- A Request from YOUR MS Peer, asking you to HELP us (MS Views and News) Make an Impact! 💙
- Common virus jab could be key in fight against multiple sclerosis
- What is the Best Diet for MS, by Aaron Boster, MD
- video: Optic Neuritis MRI Orbits Findings
- video: Remyelination in MS
- video: Curious about early MS symptoms doctors often miss?
- video: SMALL IMPROVEMENTS Matter
- video: Multiple Sclerosis Progression, Independent from relapse Activity
